HMGCR and hepatocellular carcinoma: Gyp L treatment significantly decreased the expression of HMGCS1 and HMGCR in HCC cells, leading to significant alterations in the cholesterol metabolism pathway within HCC cells and enhancement of anticancer immune responses.